Background: Giant cell arteritis (GCA) is the most frequent vasculitis in adulthood. The delay in diagnosis sets back treatment and can lead to serious consequences. Diagnosis is complex, and is followed by the classification criteria according to the American College of Rheumatology (ACR). The is an increasing interest on the utility of temporal artery ultrasound (TAUS) as a tool to evaluate inflammation on the vessel wall. Objectives: to evaluate the utility of TAUS in GCA. Methods: During 2016, 120 TAUS were carried out in 60 patients with clinical suspicion for GCA. The TAUS was carried to completion by rheumatologist with experience. The symptoms that lead to a TAUS was either one or more of these clinical scenarios: 1) cranial symptoms (recent onset headache, mandibular claudication, visual disturbances) 2) polymyalgic syndrome 3) toxic o febril unspecific syndrome 4) vertebrobasilary (VB) stroke. Demographic and laboratory data were collected, and a follow-up was done to learn the final diagnosis. As for TAUS, the "halo" sign was considered positive if an anechoic image surrounded the vessel was present, and measured >0,30 mm in both, longitudinal and transverse cuts. Other more unspecific signs as stenosis or occlusion were also registered. A temporal artery biopsy was performed whenever the physicians considered necessary, based on clinical criteria, every case in no more than 30 days. Results: Fifty-two percent were women, mean age 76±7.8 years old. Mean laboratory parameters: eritrosedimentation rate 85±41.9 mm/h, C-reactive protein 77±80 mg/L, Haemoglobin 11.4±2.2 g/L, white blood count 10,228±3,520, platelet count 310,603±123,918. The symptoms that motivated requesting the TAUS were: cranial symptoms (62.2%), toxic, unspecific, febrile syndrome (44%), polymyalgic syndrome (30%), VB stroke (5%). A temporal artery biopsy was carried out in 45% of patients (N=27); it was positive in 40.7%, negative in 40.7% and unspecific (given it reported an inflammatory histologic pattern, but without the characteristic giant cells) in 18.5%. From all 60 patients in whom a TAUS was performed, 36% were diagnosed with GCA, based on ACR criteria. The sensibility and specificity for TAUS was 80% and 94% respectively, with a posivite predictive value of 88.9% and a negative predictive value of 89.2% Conclusions: TAUS is a useful, non-invasive, fast, accessible tool for evaluating temporal arteries with a great diagnostic valu
Patients with a final GCA diagnosis (n=22) Background: Color duplex ultrasonography (CDU) is most promising tool for the assessment of large vessel giant cell arteritis (LV-GCA). There is a need to define ultrasound findings consistent with the diagnosis of GCA. Objectives: We aimed to score intima-media thickness (IMT) reference ranges for LV-GCA in polish patients. Methods: 214 patients suspected for GCA and evaluated with CDU were included in the study and followed up for min 9 months. Large vessel CDU, together with arteritis/non-arteritis categorization, were performed before or within 1 week after treatment initiation by a single physician. Vasculitis was defined as hypoechoic, homogenous, increase of IMT with distorted wall structure resulting in no clear intima-media structure, over long distance (not limited only to the place of arterial bifurcations). ROC curves were calculated. Results: GCA was diagnosed in 81 patients, polymyalgia rheumatica (PMR) in 131 (characteristics - Table 1 ). Extracranial LV-GCA was diagnosed in 43 patients: axillary vasculitis in 23 patients, common carotid artery (CCA) -24, subclavian -18, superficial femoral -11, brachial (all spreading per continuum from axillary arteritis) -8. In 83 remaining patients other diagnosis was confirmed, and they served as non-GCA/PMR controls. Mean IMT in LV-GCA was significantly higher versus controls and isolated PMR (Fig. 1) . IMT in GCA was not significantly influenced by gender, hypertension and smoking in contrast with IMT in controls.
Proposed cut off values for IMT depicting vasculitis in GCA patients are presented in Table 2 . 100% specificity for vasculitis (vs GCA without large vessel vasculitis) was reached with axillary IMT of 1.06 mm (62% sens.), subclavian -1.35 mm (38% sens.), superficial femoral -1.55 mm (60% sens.), CCA -1.27 mm (22% sens.). Background: Previous studies have shown that the majority of patients with polymyalgia rheumatica (PMR) have increased fluorodeoxyglucose (FDG)-uptake around the shoulders, hips and processes of the cervical and lumbar spine on positron emission tomography (PET) (1). The specificity of these findings for PMR is not known. Objectives: To determine the specificity and sensitivity of FDG-PET findings for the diagnosis of PMR. Methods: A prospective monocentric study in a tertiary care centre. All patients underwent FDG-PET scanning before treatment with glucocorticoids was started. The clinical suspicion of PMR was quantified by the treating physician on a scale from 1 to 5. FDG-uptake was scored visually in 12 articular regions (cervical spinous processes, lumbar spinous processes, left and right sternoclavicular joint, left and right ischial tuberosity, left and right greater trochanter, left and right hip and left and right shoulder) (score 0-2) and a total skeletal score was calculated reflecting the FDG-uptake in these 12 articular regions. ROC analysis was performed to determine the optimal clinical and total skeletal score for diagnosing PMR. The golden standard for a diagnosis of PMR was the judgment of an experienced clinician after at least six months of follow-up. Results: 99 consecutive patients with a possible clicinal diagnosis of PMR were included in this study. Sixty-seven patients were finally diagnosed with PMR while 32 patients got another diagnosis. A clinical score of 4 or more had a sensitivity
